Analyst sees uniQure's (QURE) AMT-130 as a potential Huntington’s treatment: high-dose therapy slowed cUHDRS decline 80% at 3 years.
uniQure's AMT-130 data likely remains strong enough to support accelerated approval, which isn't priced into the stock at the moment. Read more on QURE stock here.
The FDA said Monday it will make an approval decision on Uniqure's Huntington's gene therapy by May 1. But Uniqure stock fell.
ClearPoint Neuro faces heightened uncertainty after uniQure's AMT-130 48-month data disappointed. Read more on CLPT stock here.
Detailed price information for Uniqure N.V. (QURE-Q) from The Globe and Mail including charting and trades.
uniQure (NasdaqGS:QURE) is back in focus after new 36- and 48-month data for its Huntington’s gene therapy, AMT-130, sparked sharp swings in the share price and renewed debate about the program. uniQure’s share price has been hit hard in the wake of the mixed AMT-130 update, with a 7-day share price return down 36.95% and a 30-day move down 49.52%, even though the year-to-date share price return is still up 3.29% and the 3-year total shareholder return is very large at roughly 2.6x. This...
The bullish thesis for uniQure’s gene therapy for Huntington's disease is still intact, as evident in consistent and positive TFC data. Click for more on QURE.
QURE's Huntingtons gene therapy shows sustained functional benefits at 36 months, but mixed 48-month data add uncertainty.
uniQure lost more than a third of its value in a single session after Huntington's data spooked investors, but Wall Street's price target still points to triple-digit upside. Whether that gap represents opportunity or denial depends on one number that cuts both ways.
Detailed price information for Uniqure N.V. (QURE-Q) from The Globe and Mail including charting and trades.
uniQure upgraded to speculative Buy as FDA aligns on BLA path for Huntington’s gene therapy. Click for more on QURE stock.
uniQure's BLA for AMT-130 is anchored on robust 36-month data, with the FDA signaling willingness to review. Click to read more about the Buy rating for QURE.
This is the newest page. Registered accounts read further back.